Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity.

Small dense low density lipoprotein (LDL) particles have altered apolipoprotein (apo) B conformation and lowered affinity for the LDL receptor (J. Biol. Chem. 1994. 269: 511-519). Herein, we examine the interaction of small dense LDL with cell LDL receptor-independent binding sites. Compared to normal LDL, at low LDL cell media concentrations (<10 microg/ml), small dense LDL had decreased specific binding to the LDL receptor on normal fibroblasts at 4 degrees C, but a 2-fold increased binding to LDL receptor-independent cell sites. At higher LDL concentration (100 microg/ ml), LDL receptor-independent binding of small dense LDL was 4.5-fold that of normal LDL in normal fibroblasts, but greater (2- to 14- fold) in LDL receptor-negative fibroblasts. In LDL receptor-negative fibroblasts at 37 degrees C, small dense LDL had higher (3-fold) cell association than normal size LDL but no effective LDL degradation. At high LDL concentrations (> or =100 microg/ml), LDL binding to normal or LDL receptor-negative fibroblasts was not affected by several anti-apoB monoclonal antibodies or by cell pretreatment with proteases, chondroitinase, or neuraminidase. In contrast, pretreating normal and receptor-negative fibroblasts with heparinase and heparitinase decreased LDL cell binding by 35% and 50%, respectively. Similarly, preincubation of receptor-negative fibroblasts with sodium chlorate, an inhibitor of proteoglycan sulfation, decreased LDL binding by about 45%. We hypothesize that small dense LDL might be more atherogenic than normal size LDL due to decreased hepatic clearance by the LDL receptor, and enhanced anchoring to LDL receptor-independent binding sites in extrahepatic tissues (e.g., the arterial wall), a process mediated, in part, by cell surface proteoglycans.

[1]  C. Packard,et al.  Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[2]  I. Goldberg,et al.  Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. , 1997, Biochemistry.

[3]  S. Holleran,et al.  Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[4]  R. Clair,et al.  Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages. , 1997, Journal of lipid research.

[5]  UrbanOlsson,et al.  Possible Functional Interactions of Apolipoprotein B-100 Segments That Associate With Cell Proteoglycans and the ApoB/E Receptor , 1997 .

[6]  R. Krauss,et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.

[7]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[8]  J. Hokanson,et al.  LDL physical and chemical properties in familial combined hyperlipidemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Y. Yoshida,et al.  Effects of Shear Stress on Glycosaminoglycan Synthesis in Vascular Endothelial Cells a , 1994, Annals of the New York Academy of Sciences.

[10]  R. Krauss,et al.  Genetic and metabolic influences on LDL subclasses , 1994 .

[11]  I. Tabas,et al.  Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor. Cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  M. Aviram,et al.  Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. , 1994, Journal of lipid research.

[13]  Y. Kawarabayasi,et al.  Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. , 1994, The Journal of biological chemistry.

[14]  E. Levy,et al.  Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. , 1994, The Journal of biological chemistry.

[15]  J. Coresh,et al.  Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. , 1993, Journal of lipid research.

[16]  J. Witztum,et al.  Radioiodination of low density lipoprotein initiates lipid peroxidation: protection by use of antioxidants. , 1993, Journal of lipid research.

[17]  A. Tall Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.

[18]  R. Krauss,et al.  Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.

[19]  R. Mahley,et al.  Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. , 1993, The Journal of biological chemistry.

[20]  M. Krieger,et al.  Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.

[21]  G. Bondjers,et al.  Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: effects of the lipid environment. , 1993, Biochemistry.

[22]  E. Bruckert,et al.  Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. , 1993, Journal of lipid research.

[23]  J. Dietschy,et al.  Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. , 1993, Annual review of nutrition.

[24]  Y. Arad,et al.  Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. , 1992, The Journal of clinical investigation.

[25]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[26]  G. Bondjers,et al.  Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[27]  G. Bondjers,et al.  Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. , 1991, Journal of lipid research.

[28]  G. Bondjers,et al.  Molecular parameters that control the association of low density lipoprotein apo B-100 with chondroitin sulphate. , 1991, Biochimica et biophysica acta.

[29]  J. Goldstein,et al.  The low-density lipoprotein receptor-related protein: double agent or decoy? , 1991 .

[30]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  R. Krauss,et al.  Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. , 1990, Journal of lipid research.

[32]  G. Bondjers,et al.  Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. , 1990, Journal of lipid research.

[33]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[34]  Y. Marcel,et al.  Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. , 1990, The Journal of biological chemistry.

[35]  D. B. Zilversmit,et al.  Comparison of Arterial Intimal Clearances of LDL from Diabetic and Nondiabetic Cholesterol‐fed Rabbits: Differences in Intimal Clearance Explained by Size Differences , 1989, Arteriosclerosis.

[36]  A. Cardin,et al.  Molecular Modeling of Protein‐Glycosaminoglycan Interactions , 1989, Arteriosclerosis.

[37]  A. Chait,et al.  The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. , 1988, The Journal of biological chemistry.

[38]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[39]  S. Eisenberg,et al.  Neutral lipid transfer and lipolysis convert high molecular weight LDL from cholesterol-fed nonhuman primates towards normal: a molecular analysis. , 1988, Biochimica et biophysica acta.

[40]  K. Weisgraber,et al.  Human apolipoprotein B-100 heparin-binding sites. , 1987, The Journal of biological chemistry.

[41]  H. Furthmayr,et al.  Aortic endothelial cell proteoheparan sulfate. I. Isolation and characterization of plasmamembrane-associated and extracellular species. , 1987, The American journal of pathology.

[42]  D. Steinberg,et al.  Decrease in Reactive Amino Groups during Oxidation or Endothelial Cell Modification of LDL: Correlation with Changes in Receptor‐Mediated Cataboiism , 1987, Arteriosclerosis.

[43]  T. Scott-Burden,et al.  Disulfide-bonded heparan sulfate proteoglycans associated with the surfaces of cultured bovine vascular endothelial cells. , 1987, European journal of biochemistry.

[44]  S. Grundy,et al.  Kinetic Heterogeneity of Low Density Lipoproteins in Primary Hypertriglyceridemia , 1986, Arteriosclerosis.

[45]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[46]  C. Packard,et al.  Receptor-independent low-density lipoprotein catabolism. , 1986, Methods in enzymology.

[47]  R. Krauss,et al.  Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses. , 1985, The Journal of biological chemistry.

[48]  C. Packard,et al.  Fenofibrate Reduces Low Density Lipoprotein Catabolism in Hypertriglyceridemic Subjects , 1985, Arteriosclerosis.

[49]  A. Chait,et al.  Metabolism of Low-Density Lipoprotein from Patients with Diabetic Hypertriglyceridemia by Cultured Human Skin Fibroblasts , 1985, Diabetes.

[50]  J. Pearson,et al.  Surface determinants of low density lipoprotein uptake by endothelial cells. , 1984, Atherosclerosis.

[51]  A. Chait,et al.  Low-density lipoproteins modified by lipid transfer protein have altered biological activity. , 1984, Biochimica et biophysica acta.

[52]  S. Eisenberg,et al.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. , 1984, The Journal of clinical investigation.

[53]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[54]  G. Schonfeld,et al.  Differential reactivity of human low density lipoproteins with monoclonal antibodies. , 1983, Journal of lipid research.

[55]  P. Colburn,et al.  Antibodies to the heparan sulfate proteoglycans synthesized by endothelial cell cultures. , 1983, Biochimica et biophysica acta.

[56]  S. Srinivasan,et al.  Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta. , 1983, Biochimica et biophysica acta.

[57]  N. Simionescu,et al.  Visualization of the binding, endocytosis, and transcytosis of low- density lipoprotein in the arterial endothelium in situ , 1983, The Journal of cell biology.

[58]  M. Brown,et al.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.

[59]  S. Eisenberg,et al.  Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. A mechanism for losing excess cholesterol esters. , 1982, The Journal of biological chemistry.

[60]  G. Camejo The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. , 1982, Advances in lipid research.

[61]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[62]  R. Krauss,et al.  Heterogeneity of serum low density lipoproteins in normal human subjects. , 1981, Journal of lipid research.

[63]  A. Attie,et al.  Metabolism of native and of lactosylated human low density lipoprotein: evidence for two pathways for catabolism of exogenous proteins in rat hepatocytes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Y. Barenholz,et al.  In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism. , 1979, The Journal of biological chemistry.

[65]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[66]  T. Carew,et al.  Enhanced degradation of trypsin-treated low density lipoprotein by fibroblasts from a patient with homozygous familial hypercholesterolemia. , 1978, Biochimica et biophysica acta.

[67]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[68]  M. Brown,et al.  Atherosclerosis: the low-density lipoprotein receptor hypothesis. , 1977, Metabolism: clinical and experimental.

[69]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Smith,et al.  Malondialdehyde formation as an indicator of prostaglandin production by human platelets. , 1976, The Journal of laboratory and clinical medicine.

[71]  M. Brown,et al.  Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Brown,et al.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[73]  P. Iverius The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. , 1972, The Journal of biological chemistry.

[74]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[75]  G. R. Bartlett Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[76]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[77]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.